Allarity Therapeutics (ALLR) Misses Q2 EPS by 15c
Tweet
Share
E-mailGet Alerts ALLR Hot Sheet
Join SI Premium – FREE
Allarity Therapeutics (NASDAQ: ALLR) reported Q2 EPS of ($0.15).
For earnings history and earnings-related data on Allarity Therapeutics (ALLR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)
- Nasdaq to delist Davis Commodities after final action letter
- Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
